None listed
Conditions
Interventions
None listed
Sponsors
Wonkwang University Sanbon Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. adult-patients whose main diagnosis is MCI or dementia (ICD-10 F00, F01, F02, F03, F067, G30 or G31) equal to or below 85 years old among outpatients of participating institutions in the 'second stage pilot project of KM-WM collaborative treatment'. 2. patiens whose global CDR score ranges 0.5 to 2.0 ( 0.5=CDR=2.0) 3. patients who decide to participat in the study by their (or legal representative when the patient has limited ability to agree, but still can express willingness to participate) voluntary will and submit a written consent
Exclusion criteria
Exclusion criteria: 1. those who are currently participating other clinical trial 2. thos who have difficulties in participating in the study as judged by researchers such as - those who are expected to have difficulty in complying the study schedule - those who are expected to have difficulty understanding and responding to study questionnaires such as illiteracy, mental and physical weakness
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| cost per quality-adjusted life-year (cost per QALY);Incremental Cost-Effectiveness Ratio(ICER);Incremental Net Benefit;Cost-Effectiveness Acceptability Curve;Korean medical pattern identification for dementia | — |
Primary
| Measure | Time frame |
|---|---|
| Seoul-Instrumental activity of daily living (S-IADL);Montreal cognitive assessment (MoCA);Neuropsychiatric Inventory-Questionnaire (NPI-Q);EuroQoL-5 Dimension (EQ-5D);EuroQol-Visual analogue scale (EQ-VAS);Short-form of Geriatric DEpression Scale (S-GDpS);Mini-Mental State Exam (MMSE);Barthel-activity of daily living (Barthel-ADL);Clinical Dementia Rating (CDR);Global Deterioration Scale (GDS);Use of long-tern care service | — |
Countries
Korea, Republic of
Contacts
Public ContactEunHee Kim
Wonkwang University Sanbon Hospital
Outcome results
None listed